CTLA4 and hepatitis A virus infection: Hepatic histologic findings of checkpoint-inhibitor-induced hepatitis are sparse in the literature and vary depending on the type of checkpoint inhibitor (PD-1, PD-Ligand 1 or anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4)).